靶向Runx1在病理性视网膜血管生成中的作用:一种潜在的治疗途径
本研究通过转录因子基序富集分析发现RUNX1是缺氧反应的关键调控因子,利用内皮细胞条件性敲除Runx1小鼠模型、临床样本及体内外实验,发现Runx1缺失减少发育期视网膜血管网络覆盖、密度、血管进展、分支点和出芽数目,而成熟血管不受影响;RUNX1在增殖性糖尿病视网膜病变和早产儿视网膜病变患者中上调,抑制RUNX1可减少病理性新生血管,机制涉及PI3K/AKT/mTOR信号通路。
要点
- Runx1为生理性视网膜血管化所必需,其缺失减少发育期视网膜血管网络覆盖、密度、血管进展、分支点和出芽数目。
- RUNX1在增殖性糖尿病视网膜病变和早产儿视网膜病变患者中上调,抑制RUNX1可减少病理性新生血管。
- 成熟血管不受Runx1抑制影响,RUNX1通过PI3K/AKT/mTOR信号通路调控内皮细胞血管生成。
核心结论
- Runx1对生理性视网膜血管化至关重要,抑制RUNX1可能有效减少病理性新生血管。
- 作者认为靶向RUNX1可能是视网膜新生血管疾病的潜在治疗策略,在选择性抑制新生血管的同时保留成熟血管的完整性。
研究设计与样本
- 研究在缺氧和常氧人脐静脉内皮细胞中进行RNA测序分析和转录因子基序富集分析。
- 利用重组酶驱动基因Cdh5-CreERT2在小鼠内皮细胞中条件性敲除Runx1,在Runx1iECKO小鼠视网膜中测量血管覆盖、密度、血管进展、分支点和出芽数目。
- 结合临床样本及体内外实验进一步探究RUNX1的表达模式、功能和潜在治疗价值。
- 采用生物信息学和高通量测序鉴定Runx1的潜在靶基因,用RT-qPCR和蛋白质印迹分析检测PI3-激酶/AKT/mTOR通路的变化。
主要发现
- 小鼠Runx1缺失导致发育期视网膜血管网络的血管覆盖、密度、血管进展、分支点和出芽数目减少。
- 成熟血管不受Runx1抑制影响。
- 在增殖性糖尿病视网膜病变和早产儿视网膜病变患者中观察到RUNX1上调。
- 抑制RUNX1减少内皮细胞增殖、迁移和管腔形成,导致氧诱导视网膜病变中病理性新生血管减少。
- 体外实验表明RUNX1通过PI3K/AKT/mTOR信号通路调控内皮细胞血管生成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Neovascular eye diseases, such as proliferative diabetic retinopathy (PDR), wet age-related macular degeneration (wAMD) and retinopathy of prematurity (ROP), are major causes of vision loss and blindness worldwide. Our transcription factor motif enrichment analysis highlighted RUNX1 as a key regulator in the hypoxic response. The purpose of this study was to characterize how loss of Runx1 affects physiological and pathological retinal vasculature formation. METHODS: RNA-seq analysis and Transcription factor motif enrichment analysis were conducted in hypoxic and normoxic HUVECs. Conditional deletion of Runx1 in endothelial cells In mice was achieved using recombinase driver Cdh5-CreERT2. Vascular coverage, density, vessel progression, branchpoints, and sprout numbers was measured in retina of Runx1iECKO mice. The expression patterns, functions, and potential therapeutic value of RUNX1 were further explored with clinical samples, as well as in vivo and in vitro experiments. Bioinformatics and high-throughput sequencing were performed to identify potential target genes of Runx1. RT-qPCR and Western blot analyses were carried out to detect the changes of PI3-kinase/AKT/mTOR pathway. RESULTS: Loss of Runx1 in mice resulted in a reduction of the vascular coverage, density, vessel progression, branchpoints, and sprouts numbers of the retinal vascular network during its development. Notably, mature blood vessels remained unaffected by Runx1 inhibition. Upregulation of RUNX1 was observed in patients with PDR and ROP. RUNX1 Inhibition reduced endothelial cell proliferation, migration and tubule formation, leading to decreased pathological neovascularization, which is shown in oxygen-induced retinopathy. Mechanistically, in vitro experiments demonstrated that RUNX1 regulates EC angiogenesis through the PI3K/AKT/mTOR signaling pathway. CONCLUSIONS: Runx1 is essential for physiological retinal vascularization. RUNX1 Inhibition may effectively decrease pathological neovascularization. Our findings suggest that targeting RUNX1 could be a promising therapeutic strategy for retinal neovascular disorders, preserving the integrity of mature blood vessels while selectively inhibiting neovascularization.
引用
- Ding X, Zhou X, Liu X, et al. Targeting Runx1 in Pathological Retinal Angiogenesis: A Potential Therapeutic Approach. Invest Ophthalmol Vis Sci. 2025. PMID: 39946136. doi:10.1167/iovs.66.2.40
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。